COOPERS CEPRAVIN L.C. LACTATING COW INTRAMAMMARY ANTIBIOTIC

Land: Australië

Taal: Engels

Bron: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Werkstoffen:

CEFUROXINE AS CEFUROXIME SODIUM

Beschikbaar vanaf:

INTERVET AUSTRALIA PTY LIMITED

INN (Algemene Internationale Benaming):

cefuroxime as Na(83.3g/kg)

farmaceutische vorm:

MISC. INTRA MAMMARY

Samenstelling:

CEFUROXINE AS CEFUROXIME SODIUM ANTIBIOTIC Active 83.3 g/kg

Eenheden in pakket:

20x3g syrn; 4x3g syrn

klasse:

VM - Veterinary Medicine

Geproduceerd door:

INTERVET AUSTRALIA

Therapeutische categorie:

CATTLE LACTATING | BOVINE

Therapeutisch gebied:

ANTIBIOTIC & RELATED

therapeutische indicaties:

MASTITIS | SUBCLINICAL MASTITIS

Product samenvatting:

Poison schedule: 4; Withholding period: MEAT: DO NOT USE less than 7 days before slaughter for human consumption. MILK: Milk taken from cows within 72 hours (6 milkings) following last treatment MUST NOT BE USED for human consumption or su pplied for processing. This milk should not be fed to bobby calves. See Guidanc e on label to help accurate milk discard after treatment. EXPORT SLAUGHTER INTE RVAL (ESI): An ESI has not been establis hed for this product. Note—observing the meat withholding period may not be suff icient to mitigate potential risks to ex port trade. Trade advice should be sough t from Coopers Animal Health on 1800 226 511 before using this product.; Host/pest details: CATTLE LACTATING: [MASTITIS]; Poison schedule: 4; Withholding period: WHP: Meat: Do not use less than 7 days before slaughter for human consumption. Milk: Milk taken from cows within 72 hours (6 milkings) following last treat ment must not be used for human consump tion or supplied for processing. This m ilk should not be fed to bobby calves.; Host/pest details: CATTLE LACTATING: [MASTITIS]; Poison schedule: 4; Withholding period: ; Host/pest details: CATTLE LACTATING: [MASTITIS]; For broad spectrum control of mastitis-causing bacteria (including penicillin resistant strains) in lactating dairy cattle.Milk from treated cows should NOT be fed to bobby calves.

Autorisatie-status:

Registered

Autorisatie datum:

2023-07-01

Bijsluiter

INTERVET
I
MSDAH-
CLEAN LABEL COPY
Product
Name:
COOPERS CEPRAVIN
L.C.
LACTATING COW INTRAMAMMARY ANTIBIOTIC-
47941
Date:
20
JANUARY 2012
Page 1
of
7
PPC
No:
TBD
Description: Primal}'_ Packs
/Immediate
Container
I
Leaflet
Label. item Code/s:
TBD
Pack Size/s:
3g
syringe, 20X3g Syringes; 4x3g
Version#:
4
_l
Date:
23/01/2012
Syringes
Revision#:
...1
Date:
Reason
for
Update:
Update label
for
change
to
incorporate change in immediate container packaging material
and dual
cap-
change
to
leaflet instructions
PRIMARY PACKS
-
MAIN PANEL(S)
Text above
this
line
is
not
included in the label copy
PRESCRIPTION
ANIMAL
REMEDY
KEEP OUT
OF
REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
COOPERS®
CEPRAVIN®
L.C.
LACTATING
COW
INTRAMAMMARY ANTIBIOTIC
ACTIVE CONSTITUENT:
83.3g/kg CEFUROXIME (as Cefuroxime Sodium)
20
_x _
3g
SYRINGES-
OUTER CARTON
4x3g
SYRINGES-
OPTIONAL INNER CARTON
•
RLP
Approved
For broad
spectrum control
of
mastitis-causing
bacteria
(including
penicillin
resistant strains)
in
lactating dairy cattle.
20
x 3g SYRINGES
[4 x 3g SYRINGES]
[4
_x _
3g
SYRINGES]
IT
IS
ILLEGAL TO SELL THIS CARTON SEPARATELY
COO
Infopest
Verified
INTERVET
I
MSDAH-
C
LEAN
LABEL COPY
Product Name:
COOPERS CEPRAVIN
L.C
. LACTATING COW INTRAMAMMARY ANTIBIOTJC-
47941
Date:
20
JANUARY 2012
Page 2
of
7
PPC
No:
TBD
Descr!Jltion: Primary_ Packs
/Immediate
Container
I
Leaflet
Label Item Code/s:
TBD
Pack Size/s:
3g
syringe, 20X3g Syringes, 4x3g
Version#
:
4
I
Date:
23/01/2012
Syringes
Revision#:
l
Date:
Reason ·
for
Update:
Update label
for
change
to
incorporate change in immediate container packaging material
and dual
cap-
change
to
leaflet instructions
PRIMARY PACKS
-
OTHER PANELS
Text above
this
line is
not
included in the label copy
20
_x _
3g
SYRINGES-
OUTER CARTON
4x3g
SYRINGES -
OPTIONAL INNER CARTON
[20
_x _
3g
SYRINGES]
COOPERS® CEPRAVIN® L.C. LACTATING COW INTRAMAMMARY ANTIBIOTIC
Each single dose syringe of Cepravin L.
C.
contains 250
mg
cefuroxime.
Claims
Cepravin
L.C
.
is
indicated for the treatment of clinical mastitis
in
milking cows.

Productkenmerken

PRODUCT NAME: COOPERS® CEPRAVIN® LC LACTATING COW
INTRAMAMMARY ANTIBIOTIC
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Antibiotic preparation in a quick release base.
TRADE NAME:
COOPERS
® CEPRAVIN
® LC LACTATING COW INTRAMAMMARY ANTIBIOTIC
RECOMMENDED USE:
For the treatment of mastitis in dairy cows.
APVMA NO:
47941
CREATION DATE:
July, 2009
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S24/25. Avoid contact with skin and eyes.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
A dark blue suspension in single dose syringes.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. This is
an antibiotic preparation.
Any person with a history of allergies to this class of substances
should avoid all contact with this product as it may cause
sensitisation.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomfort in
normal use.
LONG TERM EXPOSURE:
No data for health effects associated with long term skin exposure.
EYE CONTACT:
SHORT TERM EXPOSURE
: This product i